The Role of Th17-Related Cytokines in Atopic Dermatitis
Open accessThe DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
Abstract
T helper-17 (Th17) cells, which mainly produce IL-17, are associated with development of various autoimmune diseases such as rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, and psoriasis. IL-17 and related cytokines are therapeutic targets of these diseases. In atopic dermatitis (AD), Th2 cytokines such as IL-4 and IL-13 are regarded to be the main player of the disease; however, Th17 cytokines are also expressed in AD skin lesions. Expression of IL-22 rather than IL-17 is predominant in AD skin, which is contrary to cytokine expression in psoriasis skin. Relatively low IL-17 expression in AD skin can induce relatively low antimicrobial peptide expression, which may be a reason why bacterial infection is frequently seen in AD patients. Failure of clinical trials for investigating the efficacy of anti-IL-12/23 p40 in AD has suggested that IL-17 expressed in skin lesions should not be the main player but a bystander responding to barrier dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Proliferation of epidermal cells, AMP expression, vascular formation, and infiltration of Th17, neutrophils, and macrophages, commonly seen in wounded skin and in psoriasis skin. We sometimes experience fungal infection in patients treated with anit-IL7A or anti-IL17 receptor A antibody. Considering that Th17 cytokines are expressed in various skin diseases with barrier dysfunction and that antibodies against IL-12/IL-23p40 or IL-17A are not effective for AD, IL-17 and its related cytokine expression can be regarded as a common defense mechanism in the skin. Relatively low AMP expression leads to a higher risk of infection seen in AD and CTCL [77,78]. Targeting the Th17 cytokine has been successful for psoriasis, but may not be always the case in other skin diseases.](https://figures.cochat.ai/paper-figures/ed84282be6714f7887f1a44756b5fdc2/the-role-of-th17-related-cytokines-in-atopic-dermatitis-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Upregulation of these receptors by PAHs can lead to disruption of the skin barrier and skewing of the immune response towards a Th2 phenotype, which is central to the development and progression of AD [23–25].”
From The Burden of Air Pollution on Skin Health: a Brief Report and Call to Action (2024) · cites this paper as [25]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873 · cited 1×
“Th17 cells, which are different from Th1 or Th2 cells, produce IL-17, IL-17F, and IL-22 as well as IL-21 [21].”
BackgroundDefensins: antimicrobial peptides of innate immunity
Ganz, T. (2003) · Nature Reviews Immunology · doi:10.1038/nri1180 · Cited by 3,066 · cited 1×
“IL-17 also increases production of antimicrobial peptides (AMPs), which are part of the innate immune response and are found among all classes of life [30,31].”
BackgroundHuman epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183 · cited 4×
“The intrinsic type is characterized by the lower expression of IL-4, IL-5, and IL-13, and the higher expression of IFN-γ.”
BackgroundInfluentialLeonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Blauvelt, A., de Bruin-Weller, M., Gooderham, M., Cather, J. C., Weisman, J., Pariser, D., Simpson, E. L., Papp, K. A., Hong, H. C.-H., Rubel, D., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31191-1 · Cited by 1,261 · cited 2×
“Cytokines Clinical Response References IL-17A Worsening of dermatitis [57–59] IL-12/23p40 No effect in clinical trial [55,56] IL-22 Effective for some patients [60,61] IL-4/13 Very effective [68]”
BackgroundSonnenberg, G. F., Fouser, L. A., & Artis, D. (2011) · Nature Immunology · doi:10.1038/ni.2025 · Cited by 1,044 · cited 2×
“IL-22, which is another cytokine expressed by Th17, enhances AMP production together with IL-17 [31].”
BackgroundA role for IL-25 and IL-33–driven type-2 innate lymphoid cells in atopic dermatitis
Salimi, M., Barlow, J. L., Saunders, S. P., Xue, L., Gutowska-Owsiak, D., Wang, X., Huang, L.-C., Johnson, D., Scanlon, S. T., McKenzie, A. N. J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20130351 · Cited by 979
Jovanović, D., Battista, J. A. D., Pelletier, J., Jolicoeur, F. C., He, Y., Zhang, M., Mineau, F., & Martel‐Pelletier, J. (1998) · PubMed · Cited by 973
Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Chaudhari, U., Romano, P., Mulcahy, L., Dooley, L., Baker, D., & Gottlieb, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04954-0 · Cited by 890
Research works printed but not linked: 1
- Furue, 2019, Pathogenesis of atopic dermatitis: CurrentpParadigm, Iran. J. Immunol., 16, 97
Cited by
JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
Huang, I.-H., Chung, W.-H., Wu, P.-C., & Chen, C.-B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1068260 · Cited by 329
“These cytokines promote cell proliferation and macrophage infiltration into damaged skin and stimulate eosinophils to secrete profibrotic cytokines (29).”
BackgroundSkin Barrier Function: The Interplay of Physical, Chemical, and Immunologic Properties
Baker, P., Huang, C., Radi, R., Moll, S. B., Jules, E., & Arbiser, J. L. (2023) · Cells · doi:10.3390/cells12232745 · Cited by 192
“IL-17 is expressed in atopic dermatitis lesions in relatively low concentrations [96].”
BackgroundExploring the Role of Staphylococcus aureus in Inflammatory Diseases
Chen, H., Zhang, J., He, Y., Lv, Z., Liang, Z., Chen, J., Li, P., Liu, J., Yang, H., Tao, A., et al. (2022) · Toxins · doi:10.3390/toxins14070464 · Cited by 179
Meng, J., Li, Y., Fischer, M. J. M., Steinhoff, M. S., Chen, W., & Wang, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696784 · Cited by 117
Current Insights into Immunology and Novel Therapeutics of Atopic Dermatitis
Kader, H. A., Azeem, M., Jwayed, S. A., Al-Shehhi, A., Tabassum, A., Ayoub, M. A., Hetta, H. F., Waheed, Y., Iratni, R., Aldhaheri, A., et al. (2021) · Cells · doi:10.3390/cells10061392 · Cited by 105
Current and Emerging Strategies to Inhibit Type 2 Inflammation in Atopic Dermatitis
Haddad, E., Cyr, S. L., Arima, K., McDonald, R. A., Levit, N. A., & Nestle, F. O. (2022) · Dermatology and Therapy · doi:10.1007/s13555-022-00737-7 · Cited by 102
“Asian patients typically have a higher expression of Th17 and Th22 cytokines and lower activation of Th1 cytokines in AD skin lesions than European–American patients; however, Th2 cytokines are upregulated consistently regardless of ethnicity or disease stage [136, 137].”
BackgroundAtopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options
Bieber, T. R. M., Paller, A. S., Kabashima, K., Feely, M. A., Rueda, M. J., Terres, J. A. R., & Wollenberg, A. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18225 · Cited by 103
Targeting lymphoid-derived IL-17 signaling to delay skin aging
Solá, P., Mereu, E., Bonjoch, J., Casado-Peláez, M., Prats, N., Aguilera, M., Reina, Ó., Blanco, E., Esteller, M., Croce, L. D., et al. (2023) · Nature Aging · doi:10.1038/s43587-023-00431-z · Cited by 93
Mouse models of atopic dermatitis: a critical reappraisal
Gilhar, A., Reich, K., Keren, A., Kabashima, K., Steinhoff, M. S., & Paus, R. (2021) · Experimental Dermatology · doi:10.1111/exd.14270 · Cited by 90
Alkon, N., Assen, F. P., Arnoldner, T., Bauer, W. M., Medjimorec, M. A., Shaw, L. E., Rindler, K., Holzer, G., Weber, P. B., Weninger, W. J., et al. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.04.019 · Cited by 87
Kim, Y. J., & Granstein, R. D. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100361 · Cited by 94
“…inflammation and defend the host from invasion against many pathogens while inappropriate Th17 responses and IL-17A production have been linked to many chronic inflammatory conditions including psoriasis, and atopic dermatitis (Cesare et al., 2008; Dhingra and Guttman-Yassky 2014; Sugaya 2020).”
BackgroundWhich Way Do We Go? Complex Interactions in Atopic Dermatitis Pathogenesis
Patrick, G. J., Archer, N. K., & Miller, L. S. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.07.006 · Cited by 85
“In addition to bacteria, commensal yeast (Malassezia spp.) can induce Th17 dependent skin inflammation on tapestripped skin (Sparber et al. 2019) Immune dysregulation alters the skin microbiome—Immune alterations can also influence the skin microbiome in AD.”
BackgroundInfluentialHemrajani, C., Negi, P., Parashar, A., Gupta, G., Jha, N. K., Singh, S. K., Chellappan, D. K., & Dua, K. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112633 · Cited by 80
Cytokines in Abdominal Aortic Aneurysm: Master Regulators With Clinical Application
Пученкова, О. А., Soldatov, V. O., Белых, А. Е., Bushueva, O., Piavchenko, G. A., Venediktov, A. A., Shakhpazyan, N. K., Deykin, A. V., Корокин, М. В., & Pokrovskiy, M. V. (2022) · Biomarker Insights · doi:10.1177/11772719221095676 · Cited by 65
Signaling pathways and targeted therapy for rosacea
Yang, F., Wang, L., Song, D., Zhang, L., Wang, X., Du, D., & Jiang, X. L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1367994 · Cited by 81
“JAK2/STAT3 activation interacts with TLR2 signaling (107), leading to increased production of pro-in fl ammatory cytokines like TNF-a , IL-6, and IL-8 (108, 109).”
BackgroundCytokines and Epidermal Lipid Abnormalities in Atopic Dermatitis: A Systematic Review
Upadhyay, P. R., Seminario‐Vidal, L., Abe, B. T., Ghobadi, C., & Sims, J. T. (2023) · Cells · doi:10.3390/cells12242793 · Cited by 67
“Studies indicate that IL-17 contributes to skin inflammation by increasing keratinocyte production of granulocyte– macrophage colony-stimulating factor (GM-CSF), TNF-α , IL-8, and vascular endothelial growth factor (VEGF) [60,61].”
BackgroundZhou, W., Cai, J., Li, Z., & Lin, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1132719 · Cited by 62
“AD is also characterized by an increase in the number of Th17 cells, which produce pro-inflammatory cytokines such as IL-17A, IL-22, and TNF-a (48).”
BackgroundBridgewood, C., Newton, D. J., Bragazzi, N. L., Wittmann, M., & McGonagle, D. (2021) · Seminars in Immunology · doi:10.1016/j.smim.2021.101520 · Cited by 59
Laska, J., Tota, M., Łacwik, J., Sędek, Ł., & Gomułka, K. (2024) · Cells · doi:10.3390/cells13161398 · Cited by 59
“…has been demonstrated to enhance epithelial integrity and facilitate tissue repair at barrier surfaces, particularly in the lungs, following inflammation, as type 3 innate lymphoid cells (ILC3s) are consti‑ tutively present in lung tissue and can rapidly produce IL‑17 and IL‑22 upon stimulation.”
BackgroundInfluentialLee, S.-J., Kim, S.-E., Shin, K.-O., Park, K., & Lee, S. E. (2021) · Allergy, Asthma & Immunology Research · doi:10.4168/aair.2021.13.5.762 · Cited by 47
The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective
David, E., Ungar, B., Renert‐Yuval, Y., Facheris, P., DUCA, E. D., & Guttman‐Yassky, E. (2023) · Clinical & Experimental Allergy · doi:10.1111/cea.14263 · Cited by 52
Tsang, M. S., Sun, X., & Wong, C. K. (2020) · Current Allergy and Asthma Reports · doi:10.1007/s11882-020-00937-1 · Cited by 48
Belpaire, A., van Geel, N., & Speeckaert, R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932265 · Cited by 48
“Th17-related cytokines seem to contribute less to the inflammatory process of atopic dermatitis (AD) (49).”
BackgroundAtopic dermatitis: Is innate or adaptive immunity in control? A clinical perspective
Ong, P. Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.943640 · Cited by 48
Novel Targeted Biological Agents for the Treatment of Atopic Dermatitis
Yang, N., Chen, Z., Zhang, X., & Shi, Y. (2021) · BioDrugs · doi:10.1007/s40259-021-00490-x · Cited by 39
The role of IL-17, IL-23 and IL-31, IL-33 in allergic skin diseases
Topal, F. A., Zuberbier, T., Makris, M. P., & Hofmann, M. A. (2020) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000658 · Cited by 37
Neutrophils in Atopic Dermatitis
Chiang, C.-C., Cheng, W.-J., Cruz, J. R. M. S. D., Raviraj, T., Wu, N., Kořínek, M., & Hwang, T. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-09004-3 · Cited by 40
Rafael‐Vidal, C., Altabás‐González, I., Pérez, N., Mouriño, C., Pego‐Reigosa, J. M., & García, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031263 · Cited by 35
New insights into immunity to skin fungi shape our understanding of health and disease
Ruchti, F., & LeibundGut‐Landmann, S. (2023) · Parasite Immunology · doi:10.1111/pim.12948 · Cited by 31
IL-17A Orchestrates Reactive Oxygen Species/HIF1α–Mediated Metabolic Reprogramming in Psoriasis
Dhamija, B., Marathe, S., Sawant, V., Basu, M., Attrish, D., Mukherjee, D., Kumar, S., Pai, M. G. J., Wad, S., Sawant, A. D., et al. (2023) · The Journal of Immunology · doi:10.4049/jimmunol.2300319 · Cited by 32
Neuwirth, T., Malzl, D., Knapp, K., Tsokkou, P., Kleißl, L., Gabriel, A., Reininger, B., Freystätter, C., Marella, N., Kutschat, A. P., et al. (2025) · Immunity · doi:10.1016/j.immuni.2025.02.011 · Cited by 36
Does the Gut Microbiota Modulate Host Physiology through Polymicrobial Biofilms?
Yang, J., Yang, Y., Ishii, M., Nagata, M., Aw, W., Obana, N., Tomita, M., Nomura, N., & Fukuda, S. (2020) · Microbes and Environments · doi:10.1264/jsme2.me20037 · Cited by 36
“A recent study suggested a relationship between AD and T helper 17 (Th17) cells (Sugaya, 2020).”
BackgroundPathogenic implication of epidermal scratch injury in psoriasis and atopic dermatitis
Furue, K., Ulzii, D., Tanaka, Y., Ito, T., Tsuji, G., Kido‐Nakahara, M., Nakahara, T., & Furue, M. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15507 · Cited by 33
Predicting persistence of atopic dermatitis in children using clinical attributes and serum proteins
Lauffer, F., Baghin, V., Standl, M., Stark, S. P., Jargosch, M., Wehrle, J., Thomas, J., Schmidt‐Weber, C. B., Biedermann, T., Eyerich, S., et al. (2020) · Allergy · doi:10.1111/all.14557 · Cited by 31
Guan, J., Li, Y., Lu, F., & Feng, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02774-7 · Cited by 30
“IL-17, a key cytokine for Th17 cells, reportedly participates in allergen-specific immune responses [54, 55], exhibits increased expression in skin trauma and skin barrier dysfunction-associated diseases [56], regulates epidermal cell proliferation conditions and skin Fig.”
BackgroundGuglielmo, A., Zengarini, C., Agostinelli, C., Motta, G., Sabattini, E., & Pileri, A. (2024) · Cells · doi:10.3390/cells13070584 · Cited by 31
“However, later studies observed that IL-15 is constitutively expressed in CTCL, with no stage-related expression [181,182].”
BackgroundAtopic Dermatitis and Psoriasis: Similarities and Differences in Metabolism and Microbiome
Chen, Y., Peng, C., Zhu, L., Wang, J., Cao, Q., Chen, X., & Li, J. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-08995-3 · Cited by 29
“Th17 cells were found to infiltrate in the lesions and blood of AD patients [36].”
Peng, S., Chen, M., Yin, M., & Feng, H. (2021) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s310426 · Cited by 29
Lee, Y. J., Yassa, C., Park, S.-H., Song, S. W., Jung, W. H., Lee, Y. W., Kang, H., & Kim, J. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076171 · Cited by 31
“Overall, Th2 immune cells are still considered the primary drivers of AD, but Th1 and Th17 cells also play important roles in the chronic inflammation and tissue damage in AD [26,29].”
BackgroundYan, C., Ying, J., Wang, L., Changzhi, Y., Qian, Q., Jingzhu, M., Dongjie, S., & Tingting, Z. (2021) · Cellular Immunology · doi:10.1016/j.cellimm.2021.104452 · Cited by 26
Yu, P., Li, K., Luo, S., Yan, R., Yi, X., Fang, C., Ma, S., Wang, G., Luo, F., Chen, X., et al. (2025) · MedComm · doi:10.1002/mco2.70425 · Cited by 28
Glycyrrhizic acid suppresses atopic dermatitis‐like symptoms by regulating the immune balance
Hou, D., Wang, X., Li, S., Wang, D., Niu, Y., Xu, Z., & Jin, Z. (2022) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.15383 · Cited by 24
Lee, E., Min, K., Ahn, H., Jeon, B., Park, S., Yun, C., Jeon, H., Yeon, J.-S., Kim, H., & Park, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179551 · Cited by 24
“During chronic or late stages of AD, Th1, Th2, and Th17 cell ratios are out of balance and cause them to interact improperly [23,24].”
BackgroundInnate lymphoid cells: a new key player in atopic dermatitis
Jia, H., Wan, H., & Zhang, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1277120 · Cited by 27
“Type 2 cytokines are usually considered to have a substantial role in AD development, whereas evidence indicates that ILC3s operate in a pathogenic function in AD through the secretion of IL-17A and IL-22 (43, 74) (Figure 3).”
BackgroundDoes age influence the quality of life in children with atopic dermatitis?
Đurović, M. R., Janković, J., Tomić-Spirić, V., Relic, M., Timotijević, Z. S., Cirkovic, A. M., Đurić, S., & Janković, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224618 · Cited by 22
Chang, S.-J., Kuo, H., Chou, W., Tsai, C., Lee, S.-Y., & Wang, L. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12071155 · Cited by 23
“Th2 cytokines like IL-4 and IL-13 are considered key players in atopic dermatitis [21].”
BackgroundFagundes, B. O., de Sousa, T. R., & Victor, J. R. (2022) · International Journal of Dermatology · doi:10.1111/ijd.16364 · Cited by 23
Huang, Y., Chen, L., Liu, F., Xiong, X., Ouyang, Y., & Deng, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1300378 · Cited by 22
Lee, J. S., Oh, E., Oh, H., Kim, S., Ok, S., Sa, J., Lee, J., Shin, Y. C., Bae, Y., Choi, C. Y., et al. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.133005 · Cited by 22
Expression of Helper and Regulatory T Cells in Atopic Dermatitis: A Meta-Analysis
Zhang, D.-J., Hao, F., Qian, T., & Cheng, H.-X. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.777992 · Cited by 22
“In wounded skin, IL-17 plays important role in wound healing, tissue regeneration, and carcinogenesis (18).”
BackgroundMartín‐Cruz, L., Benito‐Villalvilla, C., Sirvent, S., Angelina, A., & Palomares, Ó. (2024) · International Archives of Allergy and Immunology · doi:10.1159/000536335 · Cited by 25
“Emerging evidence suggests that Th22 and Th17 responses also play a role in AD development, with these CD4 + Th subsets in fi ltrating the lesional skin and peripheral blood of AD patients [158 – 161].”
BackgroundJia, Q., Hu, J. P., Wang, X., Deng, Y., Zhang, J., & Li, H. (2024) · Mycopathologia · doi:10.1007/s11046-024-00890-x · Cited by 22
“Pathogenic Th17 cells could exacerbate skin inflammation by secreting IL-17, IL-17F, IL-22, and IL-21 [11].”
A review of IL-36: an emerging therapeutic target for inflammatory dermatoses
Hwang, J., Rick, J. W., Hsiao, J. L., & Shi, V. Y. (2022) · Journal of Dermatological Treatment · doi:10.1080/09546634.2022.2067819 · Cited by 22
“Dupilumab is a monoclonal IgG that binds to the IL4R-alpha subunit to inhibit both IL-4 and IL-13 signaling (35,63,64).”
BackgroundKim, H.-O. (2022) · Archives of Pharmacal Research · doi:10.1007/s12272-022-01421-2 · Cited by 20
Advanced In Vitro Three-Dimensional Skin Models of Atopic Dermatitis
Jang, H., Lee, J. B., & Yoon, J. (2023) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-023-00532-1 · Cited by 24
“In a different study, the effects of IL-4, TNF-a, IL-17, and IL-22 on the TJ barrier were examined in an RHE model, demonstrating the inhibition of TJ proteins (ZO-1, claudin-1, claudin-4) by inflammatory cytokines, IL-17 in particular (Fig.”
BackgroundInfluentialBaidya, A., & Mabalirajan, U. (2025) · doi:10.37349/eaa.2025.100973 · Cited by 25
Ahn, J., Shin, S., Lee, G. C., Han, B. E., Lee, E. M., Ha, E. K., Shin, J., Lee, W. S., Kim, J. H., & Han, M. Y. (2024) · Allergology International · doi:10.1016/j.alit.2023.12.005 · Cited by 21
Atopic Dermatitis: The Relationship Between Immune Mediators and Skin Lipid Barrier
You, H., & Liang, Y. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09057-y · Cited by 17
“Interleukin-17 (IL-17) is produced by Th17 cells and can upregulate various cytokines and chemokines to play pro-inflammatory effects in the local inflammatory response of the epidermis in AD, such as TNF-α and Interleukin-1β (IL-1β) [166, 167].”
Understanding immunological origins of atopic dermatitis through multi-omic analysis
Beheshti, R., Halstead, S., McKeone, D., & Hicks, S. D. (2022) · Pediatric Allergy and Immunology · doi:10.1111/pai.13817 · Cited by 17
“Allergy mitigation 16 (12) 4 (10) 12 (13)”
Weng, Y., Juan, C., Ho, H. J., Chang, Y., Wu, C., & Chen, Y. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15661 · Cited by 17
DeVore, S. B., Stevens, M. L., He, H., Biagini, J. M., Kroner, J. W., Martin, L. J., & Hershey, G. K. K. (2021) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2021.07.003 · Cited by 19
Interleukin-22 in Renal Protection and Its Pathological Role in Kidney Diseases
Ma, Q., Luan, J., Bai, Y., Xu, C., Liu, F., Chen, B., Ju, D., & Xu, H. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.851818 · Cited by 20
“aureus vaccine NDV-3 injection group compared to the control group, accelerating tissue antimicrobial resistance and repair (65, 66).”
Effects of Echinocystic Acid on Atopic Dermatitis and Allergic Inflammation of the Skin and Lungs
Kang, Y., Kim, H.-M., Lee, M., & An, H. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154211 · Cited by 16
Adipokines in atopic dermatitis: the link between obesity and atopic dermatitis
Zhang, S., Zhang, B., Liu, Y., & Li, L. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02009-z · Cited by 23
“Increased secretion of IL-22 was particularly noticeable in AD [36].”
BackgroundMolecular mechanisms of obesity predisposes to atopic dermatitis
Shang, D., & Zhao, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1473105 · Cited by 18
“Additionally, Th17 and Th22 cell cytokines, such as IL13, IL-17, CCL17, tumor necrosis factor-a (TNF-a ), and IL-22, promote the formation of chronic skin lesions in AD (4).”
Kang, Y., Kim, H.-M., Lee, H., Lee, D., & An, H. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115233 · Cited by 22
Post-Translational Modifications in Atopic Dermatitis: Current Research and Clinical Relevance
Ma, X., Ru, Y., Luo, Y., Kuai, L., Chen, Q., Bai, Y. C., Liu, Y., Chen, J., Luo, Y. Y., Song, J., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.942838 · Cited by 14
“, 2000), and a correlation between TH17 cells and TH1 cells was found in the chronic phase of AD (Sugaya, 2020).”
BackgroundIL-17 Control of Cutaneous Immune Homeostasis
Johnston, L., Nagalla, R. R., Li, M., & Whitley, S. K. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2023.11.016 · Cited by 15
Kim, W. S., Seo, J. H., Lee, J. I., Ko, E.-S., Cho, S.-M., Kang, J.-R., Jeong, J.-H., Jeong, Y. J., Kim, C. Y., Cha, J., et al. (2021) · Plants · doi:10.3390/plants10040659 · Cited by 14
“, atopic dermatitis and psoriasis) by leading to a sustained and amplified inflammatory status [62].”
Transcriptome‐based identification of novel endotypes in adult atopic dermatitis
Lefèvre‐Utile, A., Saichi, M., Oláh, P., Delord, M., Homey, B., & Soumelis, V. (2021) · Allergy · doi:10.1111/all.15150 · Cited by 17
Kim, H.-M., Kang, Y., Jin, B., Lee, H., Lee, D., Lee, M., & An, H. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154579 · Cited by 14
Kim, J. H., & Samra, M. S. (2023) · Korean Journal of Pediatrics · doi:10.3345/cep.2022.00346 · Cited by 14
Potential Aspects of the Use of Cytokines in Atopic Dermatitis
Krupka‐Olek, M., Bożek, A., Aebisher, D., Bartusik‐Aebisher, D., Cieślar, G., & Kawczyk‐Krupka, A. (2024) · Biomedicines · doi:10.3390/biomedicines12040867 · Cited by 13
Lei, J., & Tominaga, M. (2024) · BioEssays · doi:10.1002/bies.202400047 · Cited by 14
“[106] Together, this evidence could indicate that TMEM79 modulates TRPV3-dependent skin homeostasis.”
BackgroundAtopic Dermatitis and Water: Is There an Optimum Water Intake Level for Improving Atopic Skin?
Douladiris, N., Vakirlis, E., & Vassilopoulou, Ε. (2023) · Children · doi:10.3390/children10020273 · Cited by 17
Lee, D., Kim, Y., Jo, H., Go, C., Jeong, Y., Jang, Y., Kang, D., Park, K., Kim, Y.-S., & Kang, J. S. (2021) · Antioxidants · doi:10.3390/antiox10060945 · Cited by 15
“IL-17 and IL-22 are closely associated with the pathogenesis of skin inflammation, especially AD [7,35,36].”
BackgroundKim, G. I., Jeong, H. Y., Kim, I. S., Lee, S. H., Kim, S.-H., Moon, Y. S., & Cho, K. K. (2024) · Food Science of Animal Resources · doi:10.5851/kosfa.2024.e100 · Cited by 13
“On the other hand, Th17 cells produce IL-17F, IL-17, IL-21, and IL-22, which are necessary for eliminating pathogens during host defense reactions (Sugaya, 2020).”
Atopic Dermatitis Management: from Conventional Therapies to Biomarker-Driven Treatment Approaches
Lee, H. W., Ju, Y. J., Choi, S., Rhew, K., Sevilleno, S. S., & Choi, M. S. (2025) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2025.081 · Cited by 14
“Primarily responsible for producing IL-17, Th17 cells are linked to the pathogenesis of several autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, and psoriasis (Sugaya, 2020).”
Lee, S. W., Park, H. J., Jeon, J., Park, Y. H., Kim, T.-C., Jeon, S. H., Seong, R. H., Kaer, L. V., & Hong, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041553 · Cited by 12
“Not only IL6 but also IL23 is essential in the pathogenesis of Th17-type AD [24].”
The Burden of Air Pollution on Skin Health: a Brief Report and Call to Action
Santiago Mangual, K. P., Ferree, S., Murase, J. E., & Kourosh, A. S. (2024) · Dermatology and Therapy · doi:10.1007/s13555-023-01080-1 · Cited by 11
“Upregulation of these receptors by PAHs can lead to disruption of the skin barrier and skewing of the immune response towards a Th2 phenotype, which is central to the development and progression of AD [23–25].”
BackgroundHaertlé, J., Kienlin, P., Begemann, G., Werfel, T., & Roesner, L. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-42595-z · Cited by 13
“Intrinsic, autoreactive as well as Asian AD have been proposed to rely to certain extent on IL-17-inflammation 37,38 .”
Lee, J.-E., Choi, Y. W., & Im, D. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115162 · Cited by 11
Swindell, W. R., Bojanowski, K., & Chaudhuri, R. K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214307 · Cited by 11
Kim, M. S., Kong, D., Han, M., Roh, K.-H., Koo, H., Lee, S., & Kang, K. (2023) · Veterinary Research Communications · doi:10.1007/s11259-023-10155-5 · Cited by 11
“Thus, IL-17-related cytokines are therapeutic targets of these diseases (Sugaya 2020).”
BackgroundWang, L., Wang, B., Kou, E., Du, L., & Zhu, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1259515 · Cited by 14
“Although the etiology and underlying mechanisms have not yet been fully elucidated, AD has been consistently characterized by a robust stimulation of TH2 immune dysfunction in skin lesions and normal skin (67, 68).”
BackgroundDing, J., Yu, X., He, J.-H., Chen, D., & Guo, F. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.912003 · Cited by 10
“KDM6B, together with KDM6A, was identi fi ed as the core regulator of T helper (Th) cells, and the inhibition of KDM6A/B contributed to the metabolic reprogramming followed by the suppression of IL-17 levels in Th17 cells, which mainly produced IL-17 cytokine (Cribbs et al., 2020; Sugaya, 2020).”
Possible roles of CXCL13/CXCR5 axis in the development of bullous pemphigoid
Ohuchi, K., Fujimura, T., Lyu, C., Amagai, R., Muto, Y., & Aiba, S. (2020) · The Journal of Dermatology · doi:10.1111/1346-8138.15713 · Cited by 10
The Wound Healing Peptide, AES16-2M, Ameliorates Atopic Dermatitis In Vivo
Kim, M. S., Song, J., Park, S., Kim, T. S., Park, H. J., & Cho, D. (2021) · Molecules · doi:10.3390/molecules26041168 · Cited by 11
“Because AD is an inflammatory disease mediated by cytokines such as IL-4, IL-13, IL-17, and thymic stromal lymphopoietin (TSLP) [10], topical corticosteroids and calcineurin inhibitors are applied as first-line therapy for AD patients in order to reduce inflammation [8].”
BackgroundHe, K., Zang, J., Ren, T., Feng, S., Liu, M., Zhang, X., Sun, W., Chu, J., Xu, D., & Liu, F. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s479444 · Cited by 10
“43 Through the pathway of IL-17R-Act1-TRAF4-MEKK3-ERK5, IL-17 enhances the proliferation of the epidermis.”
BackgroundSalvianolic Acid A Suppresses DNCB-Induced Atopic Dermatitis-Like Symptoms in BALB/c Mice
Jeon, W.-J., Lee, J., Lee, J. E., Son, S., Okajima, F., Chung, K. W., & Im, D. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/7902592 · Cited by 12
Liu, Q., Li, M., Wang, N., Chun, H., Jiang, X. L., & Li, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911371 · Cited by 10
“IL-17 has been reported to trigger Th2 responses, such as IL-4 production in AD progression, and IL-22 has been found to be positively correlated with the severity of AD [27,28].”
BackgroundWang, Y., Wu, Y., Gu, C., Wang, S., Yin, H., Zhu, R., Wang, C., Li, Z., Yao, X., & Li, W. (2023) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2023.06.002 · Cited by 9
Hyper IgE Syndromes: Understanding, Management, and Future Perspectives: A Narrative Review
Salehi, M., Neshati, Z., Ahanchian, H., Tafrishi, R., Pasdar, A., Safi, M., & Karimiani, E. G. (2025) · Health Science Reports · doi:10.1002/hsr2.70497 · Cited by 12
“Mutations in genes like STAT3 lead to disrupted cytokine signaling and hindered differentiation of Th17 cells [44, 46].”
Rundle, C. W., Rietcheck, H. R., Maghfour, J., Dercon, S., Fernandez, J., Lio, P., Dellavalle, R. P., Fujita, M., & Yardley, H. (2021) · Dermatitis · doi:10.1097/der.0000000000000722 · Cited by 9
“Importantly, TH17 and IL-17 are gaining recognition as important components in AD pathogenesis.(21) Alternatively, it is well established that PEA mediates its physiologic effects through CBRs (CBR1/2).”
BackgroundTargeting the JAK/STAT pathway in atopic dermatitis
Cui, L., Liu, P., Wu, K., Han, X., & Peng, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1757562 · Cited by 12
“STAT3 is involved in the differentiation of Th17 cells, which are more prominent in chronic AD lesions or in patients with intrinsic or Asian AD subtypes, and promotes the production of cytokines such as IL-17 and IL-22 (25 – 27).”
InfluentialJia, J., Feng, L., Ye, S., Ping, R., Mo, X., Zhang, Y., Li, X., & Chen, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.929580 · Cited by 9
“IL-17 secretion can be enhanced by the Staphylococcus aureusderived superantigen staphylococcal enterotoxin B (Sugaya, 2020).”
BackgroundShi, Y., Liu, Y., Zhang, B., Li, X., Lin, J., & Yang, C. (2023) · Cell Transplantation · doi:10.1177/09636897231154579 · Cited by 8
Dai, Y.-F., Lv, Z., You, M.-X., Sun, L., & Li, C. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108701 · Cited by 10
A real-world observational study of dupilumab treatment in adult patients with prurigo nodularis
Zhang, Z., Li, S., Wang, Y., & Zhao, J. (2023) · Anais Brasileiros de Dermatologia · doi:10.1016/j.abd.2022.09.008 · Cited by 9
Chen, P., Hsu, H.-Y., Liao, Y.-C., Lee, C.-C., Hsieh, M.-H., Kuo, W.-S., Wu, L. S., & Wang, J. (2024) · Asian Pacific Journal of Allergy and Immunology · doi:10.12932/ap-211123-1733 · Cited by 10
Metadata
- Authors
- Sugaya, M.
- Affiliations
- International University of Health and Welfare Ichikawa Medical Center (JP)
- Corresponding author
- Sugaya, Makoto
- ORCID
- Sugaya, Makoto
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-02-15
- Volume
- 21
- Issue
- 4
- Pages
- 1314
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7072946
- OpenAlex
- W3006169882
- Semantic Scholar
- 1393156b84cfca45fd4122ed4220e8af97991f3b
- Cited by
- 204
- References
- 84
- Citations by year
- 2026: 18 · 2025: 28 · 2024: 48 · 2023: 32 · 2022: 42 · 2021: 23 · 2020: 12
- FWCI
- 4.56
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
- Keywords
- atopic dermatitis, Th17 cells, IL-17, IL-22, Th2 cytokines, IL-4, IL-13, antimicrobial peptides, bacterial skin infections, skin barrier dysfunction, IL-12/23p40, psoriasis
- MeSH terms
- Interleukin-22, Dermatitis, Atopic, Humans, Interleukins, Skin, Keratinocytes, Interleukin-4, Cytokines, Interleukin-13, Interleukin-17, Antimicrobial Cationic Peptides, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.